by Admin | April 15, 2015 9:40 am
April 15, 2015—The Department of Health and Human Services Office of Inspector General has told two members of Congress that it plans to determine the amount of additional rebates Medicaid would have received if generic drugs were subject to the same penalty as brand-name drugs when their prices rise faster than the rate of inflation.
Source URL: https://340binformed.org/2015/04/oig-to-investigate-rising-generic-drug-prices/
Copyright ©2024 340binformed.org unless otherwise noted.